Motus gi holdings, inc. announces pricing of $5.0 million public offering

Fort lauderdale, fla., dec. 18, 2023 (globe newswire) -- motus gi holdings, inc. (nasdaq: mots, or “motus gi” or “the company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today the pricing of a public offering of 3,333,334 shares of common stock (or pre-funded warrants in lieu thereof), series a common warrants to purchase up to 3,333,334 shares of common stock, and series b common warrants to purchase up to 3,333,334 shares of common stock, at a combined public offering price of $1.50 per share (or pre-funded warrant in lieu thereof) and series a common warrant and series b common warrant, each to purchase one share of common stock, for aggregate gross proceeds of approximately $5.0 million, before deducting placement agent fees and other offering expenses. the series a warrants will have an exercise price of $1.50 per share, will be exercisable immediately, and will expire five years from the initial issuance date. the series b warrants will have an exercise price of $1.50 per share, will be exercisable immediately, and will expire eighteen months from the initial issuance date. the pre-funded warrants and accompanying common warrants are substantially identical, except that each pre-funded warrant is immediately exercisable for one share of common stock at an exercise price of $0.0001, the purchase price for a pre-funded warrant and accompanying common warrants is the public offering price minus $0.0001 and the pre-funded warrants do not expire until exercised.
MOTS Ratings Summary
MOTS Quant Ranking